PROCTER & GAMBLE Co·4

Feb 13, 7:01 AM ET

Moeller Jon R 4

4 · PROCTER & GAMBLE Co · Filed Feb 13, 2026

Research Summary

AI-generated summary of this filing

Updated

P&G (PG) Exec. Chairman Jon Moeller Exercises Options, Sells Shares

What Happened

  • Jon R. Moeller, Executive Chairman of Procter & Gamble (PG), exercised stock options and immediately sold the resulting shares (a cashless-style exercise and sale). Over Feb 11–12, 2026 he exercised a total of 173,268 shares (acquired at $113.23 per share) and sold all 173,268 shares in open-market transactions.
  • Breakdown: Feb 11 — 11,036 shares exercised at $113.23 (cost $1,249,606) and sold at $160.00 (gross proceeds $1,765,760). Feb 12 — 162,232 shares exercised at $113.23 (cost $18,369,529) and sold at $162.45 (gross proceeds $26,354,361). Combined exercise cost ≈ $19.62M; combined gross sale proceeds ≈ $28.12M.

Key Details

  • Transaction dates/prices: Feb 11 (exercise $113.23; sale $160.00), Feb 12 (exercise $113.23; sale weighted avg $162.45; sale price range reported $162.13–$162.65 for related trades). (Footnote: full per-price breakdown available on request.)
  • Total shares transacted: 173,268 shares exercised and 173,268 shares sold.
  • Shares owned after the transaction: not specified in the provided filing excerpt.
  • Footnotes: F1 notes weighted-average sale prices and a reported price range; F2 reflects an adjustment to PST through 12/31/2025.
  • Filing timeliness: Report filed 2026-02-13 for trades on 2026-02-11/12 — appears timely under Form 4 reporting rules.

Context

  • This was an option exercise followed by immediate sales (cashless exercise pattern), which is routine for executives realizing value from vested options and does not by itself indicate a change in company outlook.
  • Derivative reporting lines showing $0 disposals reflect the mechanics of option cancellation/settlement upon exercise and sale, not a separate cash sale.

Insider Transaction Report

Form 4
Period: 2026-02-11
Moeller Jon R
DirectorExec. Chairman of the Board
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-11$113.23/sh+11,036$1,249,606330,420.99 total
  • Sale

    Common Stock

    2026-02-11$160.00/sh11,036$1,765,760319,384.99 total
  • Exercise/Conversion

    Common Stock

    2026-02-12$113.23/sh+162,232$18,369,529481,616.99 total
  • Sale

    Common Stock

    [F1]
    2026-02-12$162.45/sh162,232$26,354,361319,384.99 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2026-02-1111,036162,232 total
    Exercise: $113.23From: 2023-02-28Exp: 2030-02-28Common Stock (11,036 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2026-02-12162,2320 total
    Exercise: $113.23From: 2023-02-28Exp: 2030-02-28Common Stock (162,232 underlying)
Holdings
  • Common Stock

    [F2]
    (indirect: By Trust)
    25,001.051
  • Common Stock

    (indirect: By Spouse)
    35,421.571
Footnotes (2)
  • [F1]Weighted average price of the shares sold. The price range was $162.13 to $162.65. Full information regarding the number of shares sold at each separate price available upon request.
  • [F2]Reflects adjustment to PST through December 31, 2025.
Signature
/s/ Wednesday Shipp, Attorney-In-Fact for Jon R. Moeller|2026-02-13

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT